This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Looking at the potential of Know Labs Non-Invasive Continuous Glucose Monitor

Ticker(s): KNWN, MDT, DXCM, ABT

Who's the expert?

Institution: East Coast Medical Associates

  • Endocringolist at East Coast Medical Associates 
  • Diabetes and Metabolism specialist who manages 150 patients with Type 1 Diabetes
  • Manages over 100 patients who utilize Continuous Glucose Monitors and is very familiar with Know Labs Non-Invasive CGM technology

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many patients with diabetes do you currently manage?

Added By: ben_admin
Q3.

How many of your diabetes patients utilize CGMs?

Added By: ben_admin
Q4.

What are the different CGM brands available currently?

Added By: ben_admin
Q5.

How beneficial would a non-invasive CGM be to patients? 

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.